The latest price target for Universal Health Servs (NYSE:UHS) was reported by JP Morgan on December 17, 2024. The analyst firm set a price target for $226.00 expecting UHS to rise to within 12 months (a possible 26.70% upside). 51 analyst firms have reported ratings in the last year.

The latest analyst rating for Universal Health Servs (NYSE:UHS) was provided by JP Morgan, and Universal Health Servs their neutral rating.

The last upgrade for Universal Health Services Inc happened on October 16, 2024 when TD Cowen raised their price target to $283. TD Cowen previously had a hold for Universal Health Services Inc.

The last downgrade for Universal Health Services Inc happened on March 1, 2023 when Wolfe Research changed their price target from N/A to N/A for Universal Health Services Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Universal Health Servs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Universal Health Servs was filed on December 17, 2024 so you should expect the next rating to be made available sometime around December 17, 2025.

While ratings are subjective and will change, the latest Universal Health Servs (UHS) rating was a with a price target of $0.00 to $226.00. The current price Universal Health Servs (UHS) is trading at is $178.37, which is within the analyst’s predicted range.